167 related articles for article (PubMed ID: 20602569)
1. Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study.
Molnár T; Farkas K; Nagy F; Lakatos PL; Miheller P; Nyári T; Horváth G; Szepes Z; Marik A; Wittmann T
Scand J Gastroenterol; 2010 Nov; 45(11):1302-6. PubMed ID: 20602569
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy and inflammatory bowel disease: a prospective case-control study.
Malgarinos G; Gikas A; Delicha E; Stamataki A; Georgopoulos F; Papadimitriou A; Stanciu C; Triantafillidis JK
Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):613-9. PubMed ID: 18293689
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study.
Dominitz JA; Young JC; Boyko EJ
Am J Gastroenterol; 2002 Mar; 97(3):641-8. PubMed ID: 11926208
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006.
Bortoli A; Pedersen N; Duricova D; D'Inca R; Gionchetti P; Panelli MR; Ardizzone S; Sanroman AL; Gisbert JP; Arena I; Riegler G; Marrollo M; Valpiani D; Corbellini A; Segato S; Castiglione F; Munkholm P;
Aliment Pharmacol Ther; 2011 Oct; 34(7):724-34. PubMed ID: 21815900
[TBL] [Abstract][Full Text] [Related]
5. Perinatal outcomes in inflammatory bowel disease.
Bush MC; Patel S; Lapinski RH; Stone JL
J Matern Fetal Neonatal Med; 2004 Apr; 15(4):237-41. PubMed ID: 15280131
[TBL] [Abstract][Full Text] [Related]
6. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
Henriksen M; Jahnsen J; Lygren I; Sauar J; Schulz T; Stray N; Vatn MH; Moum B;
Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study.
Bortoli A; Saibeni S; Tatarella M; Prada A; Beretta L; Rivolta R; Politi P; Ravelli P; Imperiali G; Colombo E; Pera A; Daperno M; Carnovali M; de Franchis R; Vecchi M;
J Gastroenterol Hepatol; 2007 Apr; 22(4):542-9. PubMed ID: 17376049
[TBL] [Abstract][Full Text] [Related]
8. Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease.
Leung YP; Kaplan GG; Coward S; Tanyingoh D; Kaplan BJ; Johnston DW; Barkema HW; Ghosh S; Panaccione R; Seow CH; ;
J Crohns Colitis; 2015 Mar; 9(3):223-30. PubMed ID: 25576754
[TBL] [Abstract][Full Text] [Related]
9. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
[TBL] [Abstract][Full Text] [Related]
10. [Inflammatory bowel diseases: gynecological and obstetrical considerations].
Amate P; Seirafi M; Bouhnik Y; Luton D; Ducarme G
J Gynecol Obstet Biol Reprod (Paris); 2011 Nov; 40(7):612-9. PubMed ID: 21733636
[TBL] [Abstract][Full Text] [Related]
11. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.
Bortlik M; Machkova N; Duricova D; Malickova K; Hrdlicka L; Lukas M; Kohout P; Shonova O; Lukas M
Scand J Gastroenterol; 2013 Aug; 48(8):951-8. PubMed ID: 23834232
[TBL] [Abstract][Full Text] [Related]
13. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
[TBL] [Abstract][Full Text] [Related]
14. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory bowel disease in children 5 years of age and younger.
Mamula P; Telega GW; Markowitz JE; Brown KA; Russo PA; Piccoli DA; Baldassano RN
Am J Gastroenterol; 2002 Aug; 97(8):2005-10. PubMed ID: 12190168
[TBL] [Abstract][Full Text] [Related]
16. The effects of pre- and post-pregnancy inflammatory bowel disease diagnosis on birth outcomes.
Raatikainen K; Mustonen J; Pajala MO; Heikkinen M; Heinonen S
Aliment Pharmacol Ther; 2011 Feb; 33(3):333-9. PubMed ID: 21138456
[TBL] [Abstract][Full Text] [Related]
17. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
Herrlinger KR; Noftz MK; Dalhoff K; Ludwig D; Stange EF; Fellermann K
Am J Gastroenterol; 2002 Feb; 97(2):377-81. PubMed ID: 11866276
[TBL] [Abstract][Full Text] [Related]
18. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.
Bröms G; Granath F; Stephansson O; Kieler H
Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352
[TBL] [Abstract][Full Text] [Related]
19. Preterm birth reduction after clotrimazole treatment during pregnancy.
Czeizel AE; Fladung B; Vargha P
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):157-63. PubMed ID: 15358456
[TBL] [Abstract][Full Text] [Related]
20. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.
Reddy D; Murphy SJ; Kane SV; Present DH; Kornbluth AA
Am J Gastroenterol; 2008 May; 103(5):1203-9. PubMed ID: 18422816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
